Wednesday, August 10, 2022

TOPIC

Novavax

Serum Institute of India all set to manufacture Novavax’s COVID-19 vaccine Covovax, trial data demonstrates 90.4 overall efficacy

Adar Poonawalla, the CEO of SII, plans to launch Novavax's Covovax in India by September contingent upon the regulatory approvals

Latest News

Recently Popular

Connect with us

255,564FansLike
592,838FollowersFollow
27,500SubscribersSubscribe